Extract from the Register of European Patents

EP About this file: EP3766877

EP3766877 - INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  28.01.2022
Database last updated on 11.04.2026
FormerExamination is in progress
Status updated on  16.12.2021
FormerRequest for examination was made
Status updated on  23.07.2021
FormerThe application has been published
Status updated on  18.12.2020
Most recent event   Tooltip28.01.2022Withdrawal of applicationpublished on 02.03.2022  [2022/09]
Applicant(s)For all designated states
Japan Tobacco Inc.
1-1, Toranomon 4-chome
Minato-ku
Tokyo 105-6927 / JP
[2021/03]
Inventor(s)01 / INOUE, Teruhiko
c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
02 / KAYA, Tetsudo
c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
03 / KIKUCHI, Shinichi
c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
04 / MATSUMURA, Koji
c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
05 / MASUO, Ritsuki
c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
06 / SUZUKI, Motoya
c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
07 / MAEKAWA, Michihide
c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho, Takatsuki-shi
Osaka 569-1125 / JP
 [2021/03]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2021/03]
Application number, filing date20189306.225.11.2010
[2021/03]
Priority number, dateJP2009026804025.11.2009         Original published format: JP 2009268040
[2021/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3766877
Date:20.01.2021
Language:EN
[2021/03]
Search report(s)(Supplementary) European search report - dispatched on:EP19.11.2020
ClassificationIPC:C07D403/04
[2021/03]
CPC:
C07D403/04 (EP,KR,US); A61K31/404 (KR); A61K31/416 (KR);
A61K31/5377 (KR); C07D401/14 (KR,US); C07D403/14 (KR,US);
C07D405/14 (KR,US); C07D413/14 (KR,US); C07D417/14 (KR,US);
C07D471/04 (KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/34]
Former [2021/03]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:INDOLVERBINDUNG UND IHRE PHARMAZEUTISCHE VERWENDUNG[2021/03]
English:INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF[2021/03]
French:COMPOSÉ D'INDOLE ET UTILISATION PHARMACEUTIQUE DE CELUI-CI[2021/03]
Examination procedure19.07.2021Amendment by applicant (claims and/or description)
19.07.2021Examination requested  [2021/34]
19.07.2021Date on which the examining division has become responsible
15.12.2021Despatch of a communication from the examining division (Time limit: M04)
27.01.2022Application withdrawn by applicant  [2022/09]
Parent application(s)   TooltipEP10833248.7  / EP2505586
EP16158053.5  / EP3059234
Fees paidRenewal fee
04.09.2020Renewal fee patent year 03
04.09.2020Renewal fee patent year 04
04.09.2020Renewal fee patent year 05
04.09.2020Renewal fee patent year 06
04.09.2020Renewal fee patent year 07
04.09.2020Renewal fee patent year 08
04.09.2020Renewal fee patent year 09
04.09.2020Renewal fee patent year 10
04.09.2020Renewal fee patent year 11
22.11.2021Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A] US2007254937  (JURCAK JOHN G et al.) [A] 1-7 * claims 1, 17 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.